1) Quest Diagnostics reported strong financial results for Q4 and full year 2007, with consolidated revenues growing 14.3% to $1.8 billion in Q4. Operating margin grew to 17.6% and cash flow was $355 million for the quarter. 2) For 2008, Quest expects revenue growth of approximately 9%, operating income as a percentage of revenues to approach 17%, cash from operations of $900 million, and diluted EPS between $3.00-$3.20, excluding potential special charges. 3) Quest aims to grow revenues above industry rates, expand operating income to 20% of revenues, and derive 10% of revenues from international business within 5 years. The company is well